FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2734493460> ?p ?o ?g. }

• W2734493460 endingPage "27" @default.
• W2734493460 startingPage "16" @default.
• W2734493460 abstract "Using the French Hemovigilance Network database from 2007 to 2013, we provide information on demographics, incidence, and risk factors of reported transfusion-related acute lung injury (TRALI) and possible TRALI, analyze TRALI mitigation efforts for fresh frozen plasma and platelet concentrates, and consider the impact of platelet additive solutions on TRALI incidence. We applied the Toronto consensus conference definitions for TRALI and possible TRALI. Two TRALI subgroups were considered: “antibody positive” when a donor has human leukocyte antigen (class I or II) and/or human neutrophil antigen antibodies and the recipient has cognate antigen, and “antibody negative” when immunological investigation is negative or not done. The analysis targeted 378 cases, divided into antibody-positive TRALI (n = 75), antibody-negative TRALI (n = 100), and possible TRALI (n = 203). TRALI patients were younger and received more blood components than the general population of transfused patients. Moreover, we identified the following clinical conditions where patients seemed to be at higher risk to develop TRALI: postpartum hemorrhage, acute myeloid leukemia, liver transplantation, allogeneic and autologous hematopoietic stem cells transplantation, polytrauma, and thrombotic microangiopathy. Policy measures intended to reduce antibody-positive TRALI were found effective for apheresis platelet concentrates and fresh frozen plasma but not for whole blood–derived platelet concentrates. The use of platelet additive solutions was associated with a significant reduction in the incidence of TRALI following transfusion of buffy coat–derived platelet concentrates but not following transfusion of apheresis platelets. Our data reinforce the concept that possible TRALI and TRALI, as defined in the Canadian consensus conference, share many characteristics. No specific policy measures are currently directed at mitigation of possible TRALI despite its impact on transfusion safety. Despite TRALI mitigation measures, the overall incidence of TRALI cases reported to the French Hemovigilance system was not significantly reduced. Therefore, additional research is needed to reduce, if not eradicate, all TRALI categories." @default.
• W2734493460 created "2017-07-21" @default.
• W2734493460 creator A5015567386 @default.
• W2734493460 creator A5022696787 @default.
• W2734493460 creator A5035337724 @default.
• W2734493460 creator A5039524178 @default.
• W2734493460 creator A5049986715 @default.
• W2734493460 creator A5055004014 @default.
• W2734493460 creator A5057067952 @default.
• W2734493460 creator A5060977894 @default.
• W2734493460 creator A5063949916 @default.
• W2734493460 creator A5071917876 @default.
• W2734493460 creator A5075917618 @default.
• W2734493460 creator A5078860100 @default.
• W2734493460 creator A5088574987 @default.
• W2734493460 creator A5089449520 @default.
• W2734493460 date "2018-01-01" @default.
• W2734493460 modified "2023-10-17" @default.
• W2734493460 title "Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013" @default.
• W2734493460 cites W116448657 @default.
• W2734493460 cites W1486735985 @default.
• W2734493460 cites W1500866440 @default.
• W2734493460 cites W1525854652 @default.
• W2734493460 cites W1546323384 @default.
• W2734493460 cites W1577750289 @default.
• W2734493460 cites W1589147999 @default.
• W2734493460 cites W1605699249 @default.
• W2734493460 cites W1888849107 @default.
• W2734493460 cites W1954183036 @default.
• W2734493460 cites W1963850275 @default.
• W2734493460 cites W1964095702 @default.
• W2734493460 cites W1964906546 @default.
• W2734493460 cites W1977972902 @default.
• W2734493460 cites W1985352910 @default.
• W2734493460 cites W1993546125 @default.
• W2734493460 cites W1996958745 @default.
• W2734493460 cites W2003150160 @default.
• W2734493460 cites W2004668542 @default.
• W2734493460 cites W2006158553 @default.
• W2734493460 cites W2010896933 @default.
• W2734493460 cites W2041359053 @default.
• W2734493460 cites W2047454746 @default.
• W2734493460 cites W2048829599 @default.
• W2734493460 cites W2053736648 @default.
• W2734493460 cites W2054375284 @default.
• W2734493460 cites W2060911689 @default.
• W2734493460 cites W2101502513 @default.
• W2734493460 cites W2105897265 @default.
• W2734493460 cites W2106438576 @default.
• W2734493460 cites W2111403445 @default.
• W2734493460 cites W2113610709 @default.
• W2734493460 cites W2118095436 @default.
• W2734493460 cites W2121530386 @default.
• W2734493460 cites W2129329533 @default.
• W2734493460 cites W2132438985 @default.
• W2734493460 cites W2134406481 @default.
• W2734493460 cites W2140878169 @default.
• W2734493460 cites W2147269621 @default.
• W2734493460 cites W2156003673 @default.
• W2734493460 cites W2157475765 @default.
• W2734493460 cites W2161805977 @default.
• W2734493460 cites W2170278665 @default.
• W2734493460 cites W2270760819 @default.
• W2734493460 cites W2300781690 @default.
• W2734493460 cites W2404674185 @default.
• W2734493460 cites W2556672459 @default.
• W2734493460 cites W2566694521 @default.
• W2734493460 doi "https://doi.org/10.1016/j.tmrv.2017.07.001" @default.
• W2734493460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28864336" @default.
• W2734493460 hasPublicationYear "2018" @default.
• W2734493460 type Work @default.
• W2734493460 sameAs 2734493460 @default.
• W2734493460 citedByCount "52" @default.
• W2734493460 countsByYear W27344934602018 @default.
• W2734493460 countsByYear W27344934602019 @default.
• W2734493460 countsByYear W27344934602020 @default.
• W2734493460 countsByYear W27344934602021 @default.
• W2734493460 countsByYear W27344934602022 @default.
• W2734493460 countsByYear W27344934602023 @default.
• W2734493460 crossrefType "journal-article" @default.
• W2734493460 hasAuthorship W2734493460A5015567386 @default.
• W2734493460 hasAuthorship W2734493460A5022696787 @default.
• W2734493460 hasAuthorship W2734493460A5035337724 @default.
• W2734493460 hasAuthorship W2734493460A5039524178 @default.
• W2734493460 hasAuthorship W2734493460A5049986715 @default.
• W2734493460 hasAuthorship W2734493460A5055004014 @default.
• W2734493460 hasAuthorship W2734493460A5057067952 @default.
• W2734493460 hasAuthorship W2734493460A5060977894 @default.
• W2734493460 hasAuthorship W2734493460A5063949916 @default.
• W2734493460 hasAuthorship W2734493460A5071917876 @default.
• W2734493460 hasAuthorship W2734493460A5075917618 @default.
• W2734493460 hasAuthorship W2734493460A5078860100 @default.
• W2734493460 hasAuthorship W2734493460A5088574987 @default.
• W2734493460 hasAuthorship W2734493460A5089449520 @default.
• W2734493460 hasConcept C120665830 @default.
• W2734493460 hasConcept C121332964 @default.
• W2734493460 hasConcept C126322002 @default.
• W2734493460 hasConcept C159654299 @default.

• next